Paari Murugan

7PUBLICATIONS
29CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersSocial epidemiologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 06, 2025
Comparative transcriptomics reveals a mixed basal, club, and hillock epithelial cell identity in castration-resistant prostate cancer.

Samuel P Pitzen, Amber N Rudenick, Yinjie Qiu

|Mar 02, 2021
Genomically Complex Human Angiosarcoma and Canine Hemangiosarcoma Establish Convergent Angiogenic Transcriptional Programs Driven by Novel Gene Fusions.

Jong Hyuk Kim, Kate Megquier, Rachael Thomas

|Oct 01, 2020
Anti-S100A4 Antibody Therapy Is Efficient in Treating Aggressive Prostate Cancer and Reversing Immunosuppression: Serum and Biopsy S100A4 as a Clinical Predictor.

Arsheed A Ganaie, Adrian P Mansini, Tabish Hussain

|Sep 15, 2020
Racial and Ethnic Differences in Sarcoma Incidence Are Independent of Census-Tract Socioeconomic Status.

Brandon J Diessner, Brenda J Weigel, Paari Murugan

|Nov 17, 2019
Exploitation of CD133 for the Targeted Imaging of Lethal Prostate Cancer.

Paige M Glumac, Joseph P Gallant, Mariya Shapovalova

|Aug 31, 2019
COMMD3:BMI1 Fusion and COMMD3 Protein Regulate C-MYC Transcription: Novel Therapeutic Target for Metastatic Prostate Cancer.

Syed Umbreen, Mudassir Meraj Banday, Anmbreen Jamroze

Pageof 2

Frequent Collaborators

2 joint publications

Eva Corey

2 joint publications

Scott M Dehm

1 joint publications

Jenny N Poynter

1 joint publications

Logan G Spector